These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7926712)

  • 1. Mediator assays in aspirin-induced asthma.
    Szczeklik A
    Allergy Proc; 1994; 15(3):135-8. PubMed ID: 7926712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
    Sladek K; Szczeklik A
    Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment.
    Tornhamre S; Ehnhage A; Kölbeck KG; Edenius C; Lindgren JA
    Clin Exp Allergy; 2002 Nov; 32(11):1566-73. PubMed ID: 12569976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An abnormality of arachidonic acid metabolism is not a generalized phenomenon in patients with aspirin-induced asthma.
    Nizankowska E; Michalska Z; Wandzilak M; Radomski M; Marcinkiewicz E; Gryglewski RJ; Szczeklik A
    Eicosanoids; 1988; 1(1):45-8. PubMed ID: 2856172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxygenase pathway and hydroperoxy acids: possible relevance to aspirin-induced asthma and hyperirritability of airways in asthmatics.
    Chand N; Altura BM
    Prostaglandins Med; 1981 Feb; 6(2):249-56. PubMed ID: 6113615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge.
    Juergens UR; Christiansen SC; Stevenson DD; Zuraw BL
    J Allergy Clin Immunol; 1992 Oct; 90(4 Pt 1):636-45. PubMed ID: 1328344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma.
    Fischer AR; Rosenberg MA; Lilly CM; Callery JC; Rubin P; Cohn J; White MV; Igarashi Y; Kaliner MA; Drazen JM
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 1):1046-56. PubMed ID: 7798537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic changes in arachidonic acid during aspirin desensitization].
    Salazar Villa RM; Zambrano Villa S
    Rev Alerg Mex; 1996; 43(3):56-61. PubMed ID: 8963642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implications.
    Ameisen JC; Capron A; Joseph M; Maclouf J; Vorng H; Pancré V; Fournier E; Wallaert B; Tonnel AB
    Int Arch Allergy Appl Immunol; 1985; 78(4):438-48. PubMed ID: 3934085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclooxygenase theory of aspirin-induced asthma.
    Szczeklik A
    Eur Respir J; 1990 May; 3(5):588-93. PubMed ID: 2115849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of aspirin on release of eoxin C4, leukotriene C4 and 15-HETE, in eosinophilic granulocytes isolated from patients with asthma.
    James A; Daham K; Backman L; Brunnström A; Tingvall T; Kumlin M; Edenius C; Dahlén SE; Dahlén B; Claesson HE
    Int Arch Allergy Immunol; 2013; 162(2):135-42. PubMed ID: 23921438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics.
    Volkman JA; Pontikes PJ
    Ann Pharmacother; 2002 Sep; 36(9):1457-61. PubMed ID: 12196067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
    Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of PGD2 metabolites as markers of mast cell activation in asthma.
    O'Sullivan S
    Acta Physiol Scand Suppl; 1999 Apr; 644():1-74. PubMed ID: 10352758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell effector mechanisms.
    Lane SJ; Lee TH
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 2):S67-71; discussion S71-2. PubMed ID: 8939179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.
    Gaber F; Daham K; Higashi A; Higashi N; Gülich A; Delin I; James A; Skedinger M; Gyllfors P; Nord M; Dahlén SE; Kumlin M; Dahlén B
    Thorax; 2008 Dec; 63(12):1076-82. PubMed ID: 18757457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased excretion of leukotriene E4 during aspirin-induced asthma.
    Knapp HR; Sladek K; Fitzgerald GA
    J Lab Clin Med; 1992 Jan; 119(1):48-51. PubMed ID: 1309376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
    Mita H; Endoh S; Kudoh M; Kawagishi Y; Kobayashi M; Taniguchi M; Akiyama K
    Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotrienes and aspirin induced asthma.
    Lee TH; Christie PE
    Thorax; 1993 Dec; 48(12):1189-90. PubMed ID: 8303620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.